S. Louise Phanstiel - Jun 5, 2025 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: Director
Signature: By: Justin Hunter For: S. Louise Phanstiel
Stock symbol: MYGN
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/6/2025, 04:05 PM
Previous filing: Sep 13, 2024
Next filing: Jun 17, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Phanstiel S. Louise	Director	322 NORTH 2200 WEST, SALT LAKE CITY	By: Justin Hunter For: S. Louise Phanstiel	2025-06-06	0001471518

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Award	$0	+49.8K	+39.01%	$0.00	177K	Jun 5, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Content

Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.